English

GENOMED INC

EDGAR

Filing (10QSB) · filed 2005-07-01

15 filing records in this dataset, filed from 2002-08-19 to 2005-07-01. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.2 thousand USD

2005-03-31 · USD

Exact inputs and evidence

Revenue: 2195 USD Source

Operating margin

-15,888.84%

2005-03-31 · %

Exact inputs and evidence

Operating Income: -348760 USD Source
Revenue: 2195 USD Source

Operating cash flow

-254 thousand USD

2005-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -254128 USD Source

Cash and cash equivalents: 274 thousand USD 2005-03-31 Source
Exact value

274071 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.71 thousand USD

2004-04-01 – 2005-03-31

Exact inputs and evidence

Revenue: 578 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 1486 USD · 2004-01-01 – 2004-09-30 Source
Revenue: 1247 USD · 2004-01-01 – 2004-06-30 Source
Revenue: 3186 USD · 2004-01-01 – 2004-12-31 Source
Revenue: 1486 USD · 2004-01-01 – 2004-09-30 Source
Revenue: 2195 USD · 2005-01-01 – 2005-03-31 Source

Net income

1.06 million USD

2004-04-01 – 2005-03-31

Exact inputs and evidence

Net income: 54476 USD · 2004-04-01 – 2004-06-30 Source
Net income: 2120661 USD · 2004-01-01 – 2004-09-30 Source
Net income: -5621723 USD · 2004-01-01 – 2004-06-30 Source
Net income: -4271293 USD · 2004-01-01 – 2004-12-31 Source
Net income: 2120661 USD · 2004-01-01 – 2004-09-30 Source
Net income: -346919 USD · 2005-01-01 – 2005-03-31 Source

Operating cash flow

-1.23 million USD

2004-04-01 – 2005-03-31

Exact inputs and evidence

Operating cash flow: -362469 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -161335 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -923907 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -362469 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -1140287 USD · 2004-01-01 – 2004-12-31 Source
Operating cash flow: -923907 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -254128 USD · 2005-01-01 – 2005-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-07-01.

Financial data available through: 2004-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2004-12-31
Operating income: 3 of 11 periods available· newest 2004-12-31
Net income: 3 of 11 periods available· newest 2004-12-31
Operating cash flow: 3 of 11 periods available· newest 2004-12-31
Capital expenditure: 3 of 11 periods available· newest 2004-12-31
assets: No compatible figures in this window
liabilities: No compatible figures in this window
Current assets: 3 of 11 periods available· newest 2004-12-31
Current liabilities: 3 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-50.3%

Prior period

USD 6,410

2003-01-01 – 2003-12-31
Current period

USD 3,186

2004-01-01 – 2004-12-31

Exact inputs and evidence

3186 − 6410 = -3224 USD

6410 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
3186 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Year-over-year change in Revenue: -3224 USD Concept: fundies:Revenue Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3186 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1067 Input fundies:Revenue: 6410 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1067
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 2.97 million

Prior period

−USD 1.3 million

2003-01-01 – 2003-12-31
Current period

−USD 4.27 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-4271293 − -1299347 = -2971946 USD

-1299347 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-4271293 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Year-over-year change in Net income: -2971946 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4271293 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1259 Input fundies:NetIncome: -1299347 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1259
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.07 million

Prior period

−USD 73,062

2003-01-01 – 2003-12-31
Current period

−USD 1.14 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-1140287 − -73062 = -1067225 USD

-73062 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-1140287 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Year-over-year change in Operating cash flow: -1067225 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1140287 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1285 Input fundies:OperatingCashFlow: -73062 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1285
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+USD 35,642

Prior period

USD 0

2003-01-01 – 2003-12-31
Current period

USD 35,642

2004-01-01 – 2004-12-31

Exact inputs and evidence

35642 − 0 = 35642 USD

0 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
35642 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Year-over-year change in Capital expenditure: 35642 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 35642 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1289 Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1289
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 3,186 100% of revenue
Operating costs Derived USD 4.28 million 134,334% of revenue
Operating income −USD 4.28 million −134,234% of revenue
Tax, interest and other Derived −USD 5,406 −170% of revenue
Net income −USD 4.27 million −134,064% of revenue

Cash

Operating cash flow −USD 1.14 million −35,791% of revenue
Capital expenditure USD 35,642 1,119% of revenue
Free cash flow Derived −USD 1.18 million −36,909% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Not shown: operating income or net income is not reported.
2003 Operating loss: operating costs were 19,029% of revenue.
2004 Operating loss: operating costs were 134,334% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	0	1511421 Derived	-1511421	70065 Derived	-1581486	-882861 Derived	Source 2002-01-01 – 2002-12-31: 0 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -1511421 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -1581486 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -682861 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 200000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	6410	1219757 Derived	-1213347	86000 Derived	-1299347	-73062 Derived	Source 2003-01-01 – 2003-12-31: 6410 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -1213347 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -1299347 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -73062 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	3186	4279885 Derived	-4276699	-5406 Derived	-4271293	-1175929 Derived	Source 2004-01-01 – 2004-12-31: 3186 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -4276699 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -4271293 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -1140287 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 35642 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2K 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	0	Revenue: 0 Open source
20032003-12-31	Revenue	6410	Revenue: 6410 Open source
20042004-12-31	Revenue	3186	Revenue: 3186 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-50.3% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 6410 Open source Revenue: 0 Open source
20042004-12-31	Year over year	-50.3%	Revenue: 3186 Open source Revenue: 6410 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -134,234.1% 2004

Net margin -134,064.4% 2004

Free cash flow margin -36,909.3% 2004

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	Not reported	Operating Income: -1511421 Open source Revenue: 0 Open source
20032003-12-31	Operating margin	-18,929%	Operating Income: -1213347 Open source Revenue: 6410 Open source
20042004-12-31	Operating margin	-134,234.1%	Operating Income: -4276699 Open source Revenue: 3186 Open source
20022002-12-31	Net margin	Not reported	Net Income: -1581486 Open source Revenue: 0 Open source
20032003-12-31	Net margin	-20,270.6%	Net Income: -1299347 Open source Revenue: 6410 Open source
20042004-12-31	Net margin	-134,064.4%	Net Income: -4271293 Open source Revenue: 3186 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -682861 Open source Capital Expenditure: 200000 Open source
20032003-12-31	Free cash flow margin	-1,139.8%	Revenue: 6410 Open source Operating Cash Flow: -73062 Open source Capital Expenditure: 0 Open source
20042004-12-31	Free cash flow margin	-36,909.3%	Revenue: 3186 Open source Operating Cash Flow: -1140287 Open source Capital Expenditure: 35642 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.1M 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-682861	Operating Cash Flow: -682861 Open source
20032003-12-31	Operating cash flow	-73062	Operating Cash Flow: -73062 Open source
20042004-12-31	Operating cash flow	-1140287	Operating Cash Flow: -1140287 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.2M 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-882861	Operating Cash Flow: -682861 Open source Capital Expenditure: 200000 Open source
20032003-12-31	Free cash flow	-73062	Operating Cash Flow: -73062 Open source Capital Expenditure: 0 Open source
20042004-12-31	Free cash flow	-1175929	Operating Cash Flow: -1140287 Open source Capital Expenditure: 35642 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	No source recorded
2004-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

1.39× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Current assets / current liabilities	0.77×	Current Assets: 186202 Open source Current Liabilities: 242150 Open source
20032003-12-31	Current assets / current liabilities	0.1×	Current Assets: 155747 Open source Current Liabilities: 1573803 Open source
20042004-12-31	Current assets / current liabilities	1.39×	Current Assets: 629426 Open source Current Liabilities: 453454 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 1.58 million Exact value Exact value: -1581486 USD 2002-01-01 – 2002-12-31: -1581486 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMED INC · 2002-12-31 GENOMED INC (edgar:1169417) Net Income: -1581486 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1581486 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001182063-04-000072.txt#2334 The citation records this snapshot. The page link may show a newer release later.	−USD 682,861 Exact value Exact value: -682861 USD 2002-01-01 – 2002-12-31: -682861 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMED INC · 2002-12-31 GENOMED INC (edgar:1169417) Operating Cash Flow: -682861 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -682861 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001182063-04-000072.txt#2347 The citation records this snapshot. The page link may show a newer release later.	USD 200,000 Exact value Exact value: 200000 USD 2002-01-01 – 2002-12-31: 200000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMED INC · 2002-12-31 GENOMED INC (edgar:1169417) Capital Expenditure: 200000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 200000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001182063-04-000072.txt#2351 The citation records this snapshot. The page link may show a newer release later.	−USD 882,861 Calculation and evidence -682861 − 200000 USD Exact free cash flow: -882861 USD 2002-01-01 – 2002-12-31: -682861 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 200000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMED INC · 2002-12-31 GENOMED INC (edgar:1169417) Free cash flow: -882861 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -682861 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001182063-04-000072.txt#2347 Input fundies:CapitalExpenditure: 200000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001182063-04-000072.txt#2351 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 1.3 million Exact value Exact value: -1299347 USD 2003-01-01 – 2003-12-31: -1299347 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMED INC · 2003-12-31 GENOMED INC (edgar:1169417) Net Income: -1299347 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1299347 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1259 The citation records this snapshot. The page link may show a newer release later.	−USD 73,062 Exact value Exact value: -73062 USD 2003-01-01 – 2003-12-31: -73062 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMED INC · 2003-12-31 GENOMED INC (edgar:1169417) Operating Cash Flow: -73062 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -73062 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1285 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMED INC · 2003-12-31 GENOMED INC (edgar:1169417) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1289 The citation records this snapshot. The page link may show a newer release later.	−USD 73,062 Calculation and evidence -73062 − 0 USD Exact free cash flow: -73062 USD 2003-01-01 – 2003-12-31: -73062 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMED INC · 2003-12-31 GENOMED INC (edgar:1169417) Free cash flow: -73062 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -73062 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1285 Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1289 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 4.27 million Exact value Exact value: -4271293 USD 2004-01-01 – 2004-12-31: -4271293 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Net Income: -4271293 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4271293 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1259 The citation records this snapshot. The page link may show a newer release later.	−USD 1.14 million Exact value Exact value: -1140287 USD 2004-01-01 – 2004-12-31: -1140287 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Operating Cash Flow: -1140287 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1140287 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1285 The citation records this snapshot. The page link may show a newer release later.	USD 35,642 Exact value Exact value: 35642 USD 2004-01-01 – 2004-12-31: 35642 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Capital Expenditure: 35642 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35642 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1289 The citation records this snapshot. The page link may show a newer release later.	−USD 1.18 million Calculation and evidence -1140287 − 35642 USD Exact free cash flow: -1175929 USD 2004-01-01 – 2004-12-31: -1140287 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 35642 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMED INC · 2004-12-31 GENOMED INC (edgar:1169417) Free cash flow: -1175929 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-06T00:41:05Z Snapshot: 75e4f8c3aaec889d96a546fcb9298995ed752487c25a797a79e57880723687fc Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169417?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1140287 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1285 Input fundies:CapitalExpenditure: 35642 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169417/0001013816-05-000180.txt#1289 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0001169417, 1169417, edgar:1169417

GENOMED INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation